Do you want to link to this External Site and leave Amgenbd.com?
You will be redirected in 5 seconds.
No, Return to Amgenbd.com
Yes, Leave Amgenbd.com
YOU ARE NOW LEAVING THE AMGENBD WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.


Major events where Amgen Business Development will have a presence.

April 2017

Event Date Location
AACR Annual Meeting Apr 1-5 Washington, D.C.
RESI Redefining Early Stage Investments Apr 4 Toronto, Canada
AAN Annual Meeting Apr 22-28 Boston, Massachusetts
Intralinks Alliance Management Breakfast Panel: The Art of Partnering Apr 27 San Diego, California

May 2017

Event Date Location
World Medical Innovation Forum May 1-3 Boston, Massachusetts
Digestive Disease Week Annual Meeting May 6-9 Chicago, Illinois
Immunology 2017 May 12-16 Washington, D.C.

June 2017

Event Date Location
3rd Annual Immuno-Oncology BD&L and Investment Forum Jun 2 Chicago, Illinois
ASCO Annual Meeting Jun 2-6 Chicago, Illinois
American Diabetes Association 77th Scientific Sessions Jun 9-13 San Diego, California
BIO International Convention Jun 19-22 San Diego, California

September 2017

Event Date Location
ESMO 2017 Congress Sep 8-12 Madrid, Spain

October 2017

Event Date Location
BIO Investor Forum Oct 17-18 San Francisco, California
BioNetwork Partnering Summit Oct 23-25 Laguna Niguel, California

November 2017

Event Date Location
22nd Annual BIO-Europe Nov 6-8 Berlin, Germany

News Releases

The news releases listed below are a sampling of Amgen announcements focused on business development.

Date Title
Dec 14, 2015 Amgen Reacquires All Product Rights To Prolia® (denosumab), XGEVA® (denosumab) And Vectibix® (panitumumab) From GSK In 48 Countries
Dec 4, 2015 Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma
Oct 13, 2015 Amgen And LabCentral Announce 2015 Golden Ticket Winners
View More